Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|May 20, 2011
Alemtuzumab induction in renal transplantationMichael J Hanaway, E Steve Woodle, Shamkant Mulgaonkar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trialPaul Martin, Ronald W Busuttil, Robert M Goldstein, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Posttransplant malignancyJennifer Trofe, Thomas M Beebe, Joseph F Buell, et al.
Transplantation|October 14, 2004
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphomaJennifer Trofe, Joseph F Buell, E Steve Woodle, et al.
Transplantation|July 29, 2003
Donors with central nervous system malignancies: are they truly safe?Joseph F Buell, Jennifer Trofe, Gopalan Sethuraman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2005
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppressionE Steve Woodle, Rita R Alloway, Joseph F Buell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2007
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipientsH T Silva, H C Yang, M Abouljoud, et al.
Pageof 7